Date published: 2025-10-25

00800 4573 8000

SCBT Portrait Logo
Seach Input

Inhibiteurs TAJ-β

TAJ-β inhibitors represent a specialized class of chemical compounds designed to specifically inhibit the function of the TAJ-β protein, a molecule known to play a role in various cellular regulatory pathways. TAJ-β inhibitors operate by binding to the active sites or key functional domains of the TAJ-β protein, thus preventing its normal activity within the cell. These inhibitors are often developed to fit the precise structural features of the TAJ-β protein, ensuring that they can effectively block its interactions or catalytic actions. The inhibitors may target different regions of the protein, such as its binding pockets or allosteric sites, depending on their mode of action and the specific mechanism by which they interfere with the protein's function. The chemical design of TAJ-β inhibitors is crucial for achieving a high degree of specificity, ensuring they interact with TAJ-β while minimizing interaction with other proteins.

TAJ-β inhibitors are synthesized using advanced organic synthesis techniques that allow the precise assembly of molecules with defined structural features. These compounds often feature a combination of hydrophobic and hydrophilic regions that are designed to complement the three-dimensional shape of the TAJ-β protein. Some inhibitors may include functional groups capable of forming strong covalent or non-covalent bonds with the protein's active sites, thereby enhancing their inhibitory potency. The solubility, stability, and reactivity of these inhibitors are carefully considered during their design, as these properties influence how effectively the inhibitor can interact with TAJ-β under different conditions. The diversity in the structural composition of TAJ-β inhibitors allows for the fine-tuning of their binding affinities, making them a valuable class of compounds for studying the biochemical functions and regulatory mechanisms associated with the TAJ-β protein.

Items  1  to  10  of  11 total

Afficher:

Nom du produitCAS #Ref. CatalogueQuantitéPrix HTCITATIONS Classement

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$30.00
$125.00
$445.00
45
(1)

Inhibe la MAPK p38, affectant potentiellement les voies de la réponse inflammatoire dans lesquelles TAJ-β pourrait être impliqué.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

inhibiteur de PI3K, pourrait perturber les voies de signalisation importantes pour la survie et la prolifération des cellules.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

inhibiteur de JNK, pourrait influencer les voies de réponse au stress et l'apoptose liées à l'activité de TAJ-β.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibiteur de MEK, affectant potentiellement la voie MAPK/ERK, ce qui pourrait être pertinent pour la fonction de TAJ-β.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Un autre inhibiteur de PI3K pourrait avoir un impact supplémentaire sur les voies de signalisation auxquelles TAJ-β est supposé participer.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

inhibiteur de mTOR, pourrait moduler la croissance cellulaire et les processus d'autophagie associés à TAJ-β.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

inhibiteur de la kinase RAF, pourrait affecter les voies de croissance et de différenciation cellulaires impliquant TAJ-β.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

Inhibiteur de la pan-caspase, influençant potentiellement les voies de l'apoptose que TAJ-β pourrait réguler.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Inhibiteur du protéasome, pourrait avoir un impact sur les voies de dégradation des protéines pertinentes pour la fonction de TAJ-β.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modifie le NF-κB et d'autres molécules de signalisation, affectant potentiellement l'inflammation et la croissance cellulaire.